skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

36 studies were found about Infecciones oportunistas, Malaria

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia

Condition: Placental Malaria Infection; HIV Infections; Stillbirth; Prematurity; Neonatal Deaths

NCT ID: NCT00270530

The Effect of Malaria on Disease Progression of HIV/AIDS

Condition: HIV Infections; Malaria

NCT ID: NCT00499876

Interactions Between HIV and Malaria in African Children

Condition: Malaria; HIV Infections

NCT ID: NCT00527800

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

Interactions Between Artemether-lumefantrine and Antiretrovirals in HIV-patients With Uncomplicated Malaria in Tanzania

Condition: Malaria, Falciparum; HIV Infections

NCT ID: NCT00885287

Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine

Condition: Malaria in Pregnancy; HIV Infections

NCT ID: NCT00970879

Relationship Between HIV and Malaria in Ugandan Children

Condition: HIV Infections; Malaria

NCT ID: NCT00356824

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Condition: HIV Infections; Malaria

NCT ID: NCT00719602

Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum

Condition: Malaria in Pregnancy; HIV Infection

NCT ID: NCT01746199

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

Condition: HIV Infections; Malaria

NCT ID: NCT00421473

Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda

Condition: Malaria in Pregnancy; HIV Infections

NCT ID: NCT00132535

Prevention of Malaria During Pregnancy Using Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: Malawi

Condition: Malaria, Falciparum; HIV Infections

NCT ID: NCT00126906

Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya

Condition: HIV Infections; Human Immunodeficiency Virus; Malaria; Plasmodium Falciparum; Diarrhea

NCT ID: NCT00914225

In-Vivo Response of P. Falciparum to Antimalarial Treatment in HIV-Infected and HIV-Uninfected Adults

Condition: Malaria; HIV; AIDS

NCT ID: NCT00144352

Safety and Immunogenicity Study of Influenza Vaccines in HIV-infected and HIV-uninfected Pregnant Women in Western Kenya

Condition: Influenza, Human; HIV; Malaria; Tetanus; Polio

NCT ID: NCT01810731

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy

Condition: Pregnancy; Malaria; HIV Infections

NCT ID: NCT00811421

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Condition: HIV Infections; Malaria

NCT ID: NCT00869700

Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy

Condition: Malaria in Pregnancy; HIV Infections

NCT ID: NCT01053325

Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Disease Progression; Immune System Diseases; Malaria; Parasitic Diseases; Pneumonia; Diarrhea; Infectious Disorder of Immune System

NCT ID: NCT01425073

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Condition: HIV Infections; Malaria

NCT ID: NCT00266058

Artemether/Lumefantrine and Nevirapine Interaction Study in HIV-infected Adults

Condition: Malaria; HIV

NCT ID: NCT00790881

Impact of Cotrimoxazole Prophylaxis for HIV-Infected Adults on Antifolate Resistance

Condition: HIV; Malaria; Diarrhea; Pneumonia; Opportunistic Infections

NCT ID: NCT00137657

Study of DDT and Loss of Clinically-Recognized Pregnancies in South Africa

Condition: Spontaneous Abortion; Malaria; Pregnancy Outcome; Stillbirth; HIV Infections

NCT ID: NCT00878098

Pharmacology of Antimalarial Therapy With or Without Antiretroviral Therapy

Condition: HIV Infection; Malaria

NCT ID: NCT01728961

Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen Repertoires

Condition: Malaria; Schistosomiasis; Hiv Infection

NCT ID: NCT01214876

Antimalarial Pharmacology in Children and Pregnant Women in Uganda

Condition: Malaria; HIV

NCT ID: NCT01717885

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Condition: HIV Infections; Malaria

NCT ID: NCT00697892

Safety and Immunogenicity of GSK Biologicals' Investigational Malaria Vaccine in HIV Infected Infants and Children

Condition: Malaria

NCT ID: NCT01148459

Comparative Evaluation of the Safety and the Efficacy of 2 Antimalarials Depending on HIV Status

Condition: Plasmodium Falciparum Malaria

NCT ID: NCT00304980

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

Condition: Visceral Leishmaniasis; Human African Trypanosomiasis; Enteric Fever; Melioidosis; Brucellosis; Leptospirosis; Relapsing Fever; Rickettsial Diseases; HIV; Tuberculosis; Malaria; Amoebic Liver Abscess

NCT ID: NCT01766830

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Condition: HIV Infections

NCT ID: NCT00373048

Impact of TMP-SMX Prophylaxis on Malaria Infection and Immunity in Children in Uganda

Condition: Malaria

NCT ID: NCT02094508

Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy

Condition: Malaria in Pregnancy

NCT ID: NCT00711906

Daily Trimethoprim-sulfamethoxazole or Weekly Chloroquine Among Adults on ART in Blantyre, Malawi

Condition: HIV

NCT ID: NCT01650558

Integrated Infectious Disease Capacity-Building Evaluation

Condition: Capacity Building; Support for Midlevel Health Professionals; Diagnostic Training

NCT ID: NCT01190540